Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.

The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria treated with two different dosage regimens of dihydroartemisinin-piperaquine were characterized. Piperaquine pharmacokinetics in 98 Burmese and Karen patients aged 3 to 55 years wer...

Descripció completa

Dades bibliogràfiques
Autors principals:	Tarning, J, Ashley, E, Lindegardh, N, Stepniewska, K, Phaiphun, L, Day, N, Mcgready, R, Ashton, M, Nosten, F, White, N
Format:	Journal article
Idioma:	English
Publicat:	2008

Ítems similars

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
per: Tarning, J, et al.
Publicat: (2007)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
per: Rijken, M, et al.
Publicat: (2011)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
per: Tarning, J, et al.
Publicat: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
per: Tarning, J, et al.
Publicat: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
per: Adam, I, et al.
Publicat: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
per: Adam, I, et al.
Publicat: (2012)

Efficacy and safety of dihydroartemisinin-piperaquine.
per: Myint, H, et al.
Publicat: (2007)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
per: Ashley, E, et al.
Publicat: (2010)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
per: Rijken, M, et al.
Publicat: (2007)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
per: Ashley, E, et al.
Publicat: (2004)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
per: Ashley, E, et al.
Publicat: (2010)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
per: Hoglund, R, et al.
Publicat: (2012)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
per: Phuc, B, et al.
Publicat: (2017)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
per: Tarning, J, et al.
Publicat: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
per: Tarning, J, et al.
Publicat: (2014)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
per: Tarning, J, et al.
Publicat: (2007)

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
per: Ashley, E, et al.
Publicat: (2005)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
per: Chotsiri, P, et al.
Publicat: (2017)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
per: Bui Quang Phuc, et al.
Publicat: (2017-04-01)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
per: Tarning, J, et al.
Publicat: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
per: Tarning, J, et al.
Publicat: (2012)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
per: Phyo, A, et al.
Publicat: (2011)

Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
per: Thanh, N, et al.
Publicat: (2017)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
per: Zongo, I, et al.
Publicat: (2014)

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
per: Tran, T, et al.
Publicat: (2004)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
per: Tarning, J, et al.
Publicat: (2008)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
per: Ashenafi Assefa, et al.
Publicat: (2022-12-01)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
per: Mytton, O, et al.
Publicat: (2007)

Pitfalls in estimating piperaquine elimination.
per: Tarning, J, et al.
Publicat: (2005)

Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment
per: Leang, R, et al.
Publicat: (2015)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
per: Permala, J, et al.
Publicat: (2017)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
per: Ashenaf Assefa, et al.
Publicat: (2023-04-01)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
per: Smithuis, F, et al.
Publicat: (2006)

Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
per: Rijken, M, et al.
Publicat: (2008)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
per: Issaka Zongo, et al.
Publicat: (2014-01-01)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
per: Hanboonkunupakarn, B, et al.
Publicat: (2014)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
per: Tarning, J, et al.
Publicat: (2014)

Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
per: Wanting Wu, et al.
Publicat: (2021-02-01)

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
per: van Der Pluijm, R, et al.
Publicat: (2019)

Quantification of the antimalarial piperaquine in plasma.
per: Tarning, J, et al.
Publicat: (2008)